Skip to NavigationSkip to content

News

China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent (...
The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together under the...
The Independent SAGE group has warned that it is not safe to relax social distancing rules for indoor settings, after the government’s expected...
The National Institutes of Health (NIH) have suspended clinical trials of hydroxychloroquine after the drug was found to have no real benefit in...
Germany’s coronavirus R number has drastically increased while the world faced its largest increase in cases since the pandemic began.
It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to reserve or buy upfront the...
Genentech and Roche have released new Phase 3 on the efficacy of their immunotheraoy drug Tecentriq (atezolizumab), when used in combination with...
Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread of the...
The FDA has approved Crysvita (burosumabtwza) injection to treat patients over two years old with tumour-induced osteomalacia (TIO).
The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning in July, while Sanofi...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches